Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 29%
Sell 14%
Strong Sell 0%

Bulls say

Addus HomeCare is well-positioned to continue its growth through acquisitions, especially in states such as Indiana where it has recently made two acquisitions. The company has a strong financial position with $103 million in cash and $94 million in total debt, allowing for further M&A transactions. With a focus on personal care and hospice, ADUS is well-aligned with favorable regulatory conditions and potential rate improvements. Despite the recent decline in share price, the company's strong fundamentals and potential for growth make it an attractive investment opportunity.

Bears say

Addus HomeCare is facing potential policy changes that could negatively impact its Personal Care segment, which generates the majority of their revenue. With organic growth and revenue per hour improving and hospice segment reporting declines, there are concerns about the company's overall growth potential. The company also faces risks in terms of future Medicaid funding reforms and labor constraints in its clinical businesses, which could hinder long-term growth targets.

Addus HomeCare (ADUS) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 7 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Sep 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $127.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $127.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.